Rothschild Investment LLC’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.5K Buy
224
+1
+0.4% +$196 ﹤0.01% 1264
2026
Q1
$43.7K Buy
223
+13
+6% +$2.53K ﹤0.01% 1154
2025
Q4
$36.4K Sell
210
-8
-4% -$1.46K ﹤0.01% 1124
2025
Q3
$41.5K Buy
218
+18
+9% +$3.19K ﹤0.01% 1046
2025
Q2
$35.9K Buy
200
+5
+3% +$868 ﹤0.01% 862
2025
Q1
$33K Buy
195
+1
+0.5% +$164 ﹤0.01% 879
2024
Q4
$29.3K Buy
194
+9
+5% +$1.4K ﹤0.01% 910
2024
Q3
$28.7K Sell
185
-3
-2% -$448 ﹤0.01% 916
2024
Q2
$25.7K Buy
188
+5
+3% +$685 ﹤0.01% 914
2024
Q1
$24.4K Buy
183
+34
+23% +$4.41K ﹤0.01% 883
2023
Q4
$20.5K Buy
+149
New +$19.6K ﹤0.01% 858

Other funds holding DGX

Rothschild Investment LLC's DGX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Quest Diagnostics (DGX) stake by 0.45% in Q2 2026, buying an estimated $196 and bringing the position to 224 shares worth $47.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Rothschild Investment LLC first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Rothschild Investment LLC held 224 shares of Quest Diagnostics worth $47.5K as of Q2 2026.
  • Rothschild Investment LLC bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1264 holding.
  • Rothschild Investment LLC first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.